Semaglutide
GLP-1 receptor agonist- Once-weekly injection
- Reduces appetite
- Slower but steady weight reduction
Weight management
Medical Weight Management & Metabolic Therapy
Our medical weight management program uses FDA-approved injectable therapies (such as Semaglutide and Tirzepatide) to help regulate appetite, reduce cravings, improve insulin sensitivity, and support sustainable weight reduction. Each patient receives individualized dosing, monitoring, and guidance from our licensed medical provider.
- Suppresses appetite
- Helps stabilize blood sugar
- Supports long-term fat loss
Compare
Two injectable options
Tirzepatide
Dual GLP-1 / GIP receptor agonist- Once-weekly injection
- Dual receptor activation
- Faster fat loss & stronger effects
Good to know
Frequently Asked Questions
Most patients begin noticing changes within 2–4 weeks.
Evaluation and eligibility screening may be required.
All injections are administered according to professional medical guidelines.
Your provider will advise on lifestyle guidance to help maintain weight results long-term.